RZH
MRK icon

Relyea Zuckerberg Hanson’s Merck MRK Stock Holding History

Relyea Zuckerberg Hanson’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Sell
10,095
-249
-2% -$29.1K 0.11% 103
2026
Q1 		$1.24M Sell
10,344
-3,263
-24% -$377K 0.13% 88
2025
Q4 		$1.43M Buy
13,607
+3,912
+40% +$367K 0.14% 85
2025
Q3 		$814K Sell
9,695
-65
-0.7% -$5.35K 0.09% 116
2025
Q2 		$773K Sell
9,760
-1,261
-11% -$100K 0.09% 113
2025
Q1 		$989K Sell
11,021
-790
-7% -$73.8K 0.13% 94
2024
Q4 		$1.17M Buy
11,811
+3,131
+36% +$323K 0.16% 85
2024
Q3 		$986K Sell
8,680
-606
-7% -$72K 0.15% 84
2024
Q2 		$1.15M Buy
9,286
+862
+10% +$111K 0.19% 75
2024
Q1 		$1.11M Buy
8,424
+388
+5% +$47.8K 0.19% 71
2023
Q4 		$876K Sell
8,036
-223
-3% -$23.1K 0.17% 79
2023
Q3 		$850K Buy
8,259
+146
+2% +$15.7K 0.19% 76
2023
Q2 		$936K Buy
8,113
+121
+2% +$13.7K 0.21% 70
2023
Q1 		$850K Buy
7,992
+770
+11% +$83.1K 0.21% 69
2022
Q4 		$801K Buy
7,222
+1,176
+19% +$120K 0.23% 66
2022
Q3 		$521K Buy
6,046
+385
+7% +$34.4K 0.19% 81
2022
Q2 		$516K Buy
5,661
+426
+8% +$37.8K 0.19% 84
2022
Q1 		$451K Buy
5,235
+1,382
+36% +$109K 0.15% 103
2021
Q4 		$308K Buy
3,853
+366
+10% +$29.2K 0.11% 123
2021
Q3 		$262K Buy
3,487
+414
+13% +$31.5K 0.1% 125
2021
Q2 		$239K Buy
3,073
+121
+4% +$9K 0.1% 121
2021
Q1 		$218K Sell
2,952
-728
-20% -$53.7K 0.1% 120
2020
Q4 		$287K Sell
3,680
-68
-2% -$5.2K 0.15% 95
2020
Q3 		$283K Buy
3,748
+68
+2% +$5.33K 0.18% 91
2020
Q2 		$272K Sell
3,680
-118
-3% -$8.88K 0.22% 90
2020
Q1 		$279K Hold
3,798
– – 0.31% 77
2019
Q4 		$330K Buy
+3,798
New +$312K 0.32% 72

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Relyea Zuckerberg Hanson's MRK Position: Q2 2026 in Review

Relyea Zuckerberg Hanson reduced its Merck (MRK) stake by 2.4% in Q2 2026, selling an estimated $29.1K and leaving 10,095 shares worth $1.3M. The position accounts for 0.11% of the portfolio, ranked #103.

Relyea Zuckerberg Hanson first reported a position in MRK in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.43M in Q4 2025. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Relyea Zuckerberg Hanson held 10,095 shares of Merck worth $1.3M as of Q2 2026.
  • Relyea Zuckerberg Hanson sold 249 Merck shares in Q2 2026, an estimated $29.1K.
  • Merck made up 0.11% of Relyea Zuckerberg Hanson's portfolio in Q2 2026, its #103 holding.
  • Relyea Zuckerberg Hanson first reported a position in Merck in Q4 2019 and has held it in 27 quarters since.
  • Relyea Zuckerberg Hanson's Merck position peaked at $1.43M in Q4 2025.
  • 3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Relyea Zuckerberg Hanson's 13F filing for Q2 2026, filed 16 Jul 2026.